Editorial Board ::: Current Neuropharmacology

ISSN: 1875-6190 (Online)
ISSN: 1570-159X (Print)


Volume 14, 8 Issues, 2016


Download PDF Flyer




Current Neuropharmacology

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 72nd of 256 in Neuroscience
  • 24th of 253 in Pharmacology & Pharmacy

Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
T.E. Salt
University College London
Institute of Ophthalmology
London EC1V 9EL
UK


View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 3.753
5 - Year: 3.478

Editorial Board

Editor-in-Chief:

T.E. Salt (Biography
T.E. Salt

Professor Tom Salt obtained his Degrees from The Universities of Cambridge and Bristol, is co-founder and Director of Neurexpert Ltd, and Emeritus Professor at University College London. He has worked in the pharmaceutical industry, and acted as a consultant and adviser to industry.

Professor Salt's research encompasses the pharmacology of neurotransmitters in relation to the sensory system systems, and more recently the functional consequences of neurodegeneration. He has published over 200 research and review papers, and is a member of several editorial boards and Editor in Chief of "Current Neuropharmacology"

)

University College London
Institute of Ophthalmology
London EC1V 9EL
UK



Regional Editor(s):

N. Iwata (Biography
N. Iwata

Dr. Nobuhisa Iwata obtained a Ph.D. in Pharmacology from Tokyo University of Pharmacy and Life Sciences (Tokyo, Japan), then worked at National Institute of Health Sciences (Tokyo, Japan), Tokyo Medical University (Tokyo, Japan), National Heart, Lung, and Blood Institute (Bethesda, US), and RIEKN Brain Science Institute (Wako, Japan). Currently Dr. Iwata is a full professor in Graduate School of Biomedical Sciences, Nagasaki University. He has published more than 100 scientific publications, including Science, Nature Medicine, Nature Neuroscience, Neuron, Cell Stem Cell, etc.

Dr. Iwata was appointed the Regional Editor of this journal (Current Neuropharmacology, CN), published by Bentham Science Publishers, in 2004.

)

Nagasaki University
Japan


Editorial Board Members:

I. Abraham
Univ of Pecs
Pecs
Hungary

G. Akk
Washington University School of Medicine
St. Louis, MO
USA

B. K. Alldredge
University of California
San Francisco, CA
USA

G. W. Arbuthnott
Okinawa Institute of Science and Technology Promotion Corporation
Okinawa
Japan

C. S. Atwood (Biography
C. S. Atwood

Dr. Atwood obtained his Ph.D. in Biochemistry from the University of Western Australia, Perth, Australia. He has held faculty positions at Harvard Medical School and Case Western Reserve University prior to his current appointments as an Associate Professor in the University of Wisconsin-Madison Department of Medicine, and as a Health Science Specialist within the Geriatric Research, Education and Clinical Center at the William S. Middleton Memorial Veterans Administration Hospital, Madison. He has published more than 150 scientific publications, is an inventor on 8 issued U.S. patents and is a top cited author (h-index =45). He has received a number of awards for his teaching and research, including the Zenith Fellows Award from the Alzheimer’s Association.

)

University of Wisconsin-Madison School of Medicine and Public Health
Madison, WI
USA

R. Bakalova
National Institute of Radiological Sciences (NIRS)
Chiba
Japan

L. Ballerini
University of Trieste
Trieste
Italy

A. M. Barr
University of British Columbia
Vancouver, BC
Canada

M. Baudry
University of Southern California
Los Angeles, CA
USA

S. M. Belcher
University of Cincinnati
Cincinnati
USA

S. C. Benoit
University of Cincinnati
Cincinnati, OH
USA

C. Beyer
Universittsklinikum RWTH Aachen
Aachen
Germany

A. Blokland
Maastricht University
Maastricht
The Netherlands

V. Bolshakov
Harvard Medical School
Belmont, MA
USA

O. Boutaud
Vanderbilt University
Nashville, TN
USA

K-H. Braunewell
Southern Research Institute
Magdeburg
UK

R. M. Buijs (Biography
R. M. Buijs

Dr. Ruud M. Buijs obtained a doctorate (Ph.D.) in Neuroscience from the University of Amsterdam, The Netherlands. Dr. Buijs was senior scientist and associate director of the Netherlands Institute for Brain Research and currently is senior scientist at the Biomedical Research Institute at the UNAM Mexico. He has published more than 220 scientific publications mainly on hypothalamic integration mechanisms with an emphasis in the last 10 years on the influence of the biological clock the suprachiasmatic nucleus.

)

Universidad Nacional Autonoma de Mexico
Mexico

J. L. Cadet
Univ. College of Physicians and Surgeons
Baltimore, MD
USA

D. J. Calkins ()
Vanderbilt University Medical Center
Nashville, TN
USA

C. A. Costa
Institut de Pharmacologie Molculaire et Cellulaire
France

R. G. Hill (Biography
R. G. Hill

Dr Hill received his academic training at the University of London. He was a lecturer in Pharmacology at the University of Bristol School of Medicine from 1974 to 1983 and supervisor in Pharmacology at Downing College, University of Cambridge from 1983 to 1988. He joined the pharmaceutical industry in 1983 as Head of Biology at the Park Davis Research Unit, Cambridge. In 1988 he joined Smith, Kline and French (UK) as Group Director, Pharmacology. From 1990 until his retirement in 2008 he worked in drug discovery research for Merck / MSD. He serves on the editorial boards of a number of journals, has been a Council Member of the British Pain Society, is President Emeritus, British Pharmacological Society and was coopted Member of Council, Academy of Medical Sciences. Between 1996 and 2003 he was a member of the ABPI R&D committee and was a member of the EFPIA Research Directors Group until 2008. He was a member of the Nuffield Council on Bioethics until 2013 and is a member of the Advisory Council on the Misuse of Drugs.

Dr Hill has published more than 200 peer reviewed papers on the pharmacology of opioids and other analgesic drugs and on the role of substance P, CGRP, bradykinin and other peptides in emesis, nociception and the control of food intake. He is co-author (with J.A. Alexander) of a text book on Postoperative Pain Control and (with HP Rang) of one on Drug Discovery and Development.

)

Merck Sharp & Dohme Res. Lab
Essex
UK

M. Kano
Kanazawa University
Kanazawa
Japan

H. Mancebo
Multispan Inc.,
Hayward, CA
USA

F. Moroni
Università di Firenze,Italy
Firenze
Italy

P. J. Nathan (Biography
P. J. Nathan

Prof. Pradeep Nathan is Vice President, CNS Clinical Development and Experimental Medicine at Heptares Therapeutics, and Professor of Neuroscience at Monash University. He read pharmacology and neuroscience at the University of Melbourne followed by a PhD in Neuroscience. He has more than 20 years clinical research experience and held positions in both academia and industry.

Prof. Nathan has published more than 200 research papers and his research has been cited over 8500 times in academic journals. He has received many research awards including the Australian Young Tall Poppy Science Award, the Brain and Behaviour Foundation, Independent Investigator Award and the British Association for Psychopharmacology, Clinical Psychopharmacology Award.

Biography
F. Nicoletti
)

Monash University
Australia

J. Rajadas
Stanford University
Stanford, CA
USA

M J. Sheardown
Independent Consultant
Cambridge
UK

J. H. Abraini
Univ. of Caen - Basse Normandie
Caen
France

A. P. Aldenkamp
Maastricht Univ. Med. Centre
Maastricht
The Netherlands

A. H.K. Anandatheerthavarada
University of Pennsylvania
Philadelphia, PA
USA

J. C. Arnold
The University of Sydney, New South Wales
Australia

M. Avoli
McGill Univ
Montreal
Canada

V. J. Balcar
The University of Sydney
Sydney
Australia

J. R. Bamburg
Colorado State University
Fort Collins, Co
USA

A. Baskys
University of California
Berkley, CA
USA

M. S. Beattie
University of California
San Francisco, CA
USA

F. Benedetti
University of Turin Medical School
Turin
Italy

C. Bergmann
RWTH Aachen University
Aachen
Germany

P. G. Bhide
Massachusetts General Hospital
Charlestown, MA
USA

S. Boehm (Biography
S. Boehm

Dr. Boehm obtained an MD from the University of Vienna, Austria, in 1987 and received his postdoctoral education in Vienna and Frankfurt/Main, Germany. He had been Professor of Neuropharmacology at the Medical University of Graz and was appointed Professor of Neuropharmacology at the Medical University of Vienna in 2007. There, he is head of the Department of Neurophysiology and Neuropharmacology at the Center for Physiology and Pharmacology and Director of the Doctoral School. His research focuses on mechanisms underlying pre‐ as well as postsynaptic modulation of synaptic transmission and on mechanisms of action of analgesic as well as anticonvulsant drugs.

)

Medical University of Vienna
Vienna
Austria

U. Bonuccelli
Dipartimento di Neuroscienze-Universita di Pisa
Rome
Italy

Derek Bowie (Biography
Derek Bowie

Dr. Derek Bowie earned his doctorate from the University of London, held postdoctoral fellow positions at the Université Louis Pasteur (France), University of Zurich (Switzerland) and the National Institutes of Health (USA) before joining the faculty at Emory University in Atlanta. He joined McGill in 2002 and is currently a Full Professor and Director of GEPROM, a FRQS-funded research group of McGill, Concordia and Université de Montréal. He serves/served on the editorial boards of several periodicals (e.g. Journal of Physiology, Current Neuropharmacology, European Journal of Neuroscience).

)

McGill Univ.
Montreal
Canada

D. J. Brooks
Imperial College London
London
UK

G. Burnstock (Biography
G. Burnstock

Professor Geoffrey Burnstock completed his PhD at King's College and University College London. He was head of the Department of Zoology, Melbourne University (1964-1975) before moving to London to head the Department of Anatomy and Developmental Biology, UCL until 1997. He is currently President of the Autonomic Neuroscience Centre, University College Medical School, UK. He is a Fellow of the Australian Academy of Sciences (1971), Royal Society (1986) and Academy of Medical Sciences (1998). He was awarded the Royal Society Gold Medal (2000) and has over 1530 publications and an h-index of 138.

)

University College Medical School
London
UK

P. Calabresi
University of Perugia
Perugia
Italy

M. Capogna
Medical Research Council, Anatomical Neuropharmacology. Unit of Oxford
Oxford
UK

A. Dray
Astra Zeneca Res & Devol
Montreal
Canada

A.K. Houghton
Merck & Co
West Point, PA
USA

H-G. Lee
Case Western Reserve University
Cleveland, OH
USA

F. A. Meunier (Biography
F. A. Meunier

Professor Frederic Meunier obtained his Masters degree in Neurophysiology at the Paris XI University, France in 1992 and completed his Ph.D in Neurobiology at the CNRS in Gif-sur-Yvette, France in 1996. He was the recipient of a European Biotechnology Fellowship and went on to postgraduate work at the Department of Biochemistry at Imperial College (1997-1999) and at Cancer Research UK (2000-2002) in London, UK. After a short sabbatical at the LMB-MRC in Cambridge (UK), he became a group leader at the School of Biomedical Sciences at the University of Queensland (Australia) in 2003. He joined the Queensland Brain Institute of the University of Queensland in 2007 and obtained an NHMRC senior research fellowship in 2009 renewed in 2014 with promotion. In 2014 he was also promoted to Professor and joined the Centre for Ageing Dementia Research at QBI. His laboratory works on the mechanism of vesicular trafficking in neurons and has identified critical roles for various proteins such as Munc18 and phosphoinositides such as phosphatidylinositol (4,5) bisphosphate in priming secretory vesicles. Prof Meunier has pioneered the use of single molecule imaging and super-resolution microscopy in Queensland.

)

The University of Queensland
Queensland
Australia

P.C. Moser
Institut de Recherche Pierre Fabre
Castres
France

F. Nicoletti
Univ. Rome"da Sapienza"
Rome
Italy

M.A. Rogawski
Nat. Inst. Neuro. Disorders & Stroke
Bethesda, MD
USA

K. Suk (Biography
K. Suk

Dr. Kyoungho Suk is a member of editorial board for the journal. He is currently a professor of Department of Pharmacology, Kyungpook National University (KNU) School of Medicine (Daegu, Korea), and the director of Brain Science & Engineering Institute of KNU. He obtained his Ph.D. in Immunology at University of California at Davis in 1994, and M.S. degree in Immunology at Cornell University in 1991. He graduated from KNU with the genetic engineering major in 1989. Dr. Suk received his postdoctoral training in the division of Rheumatology, Yale University School of Medicine, and he has been a visiting professor at Harvard Medical School between 2008 and 2009, during which he participated in large-scale experiments and systems biology approaches toward understanding of disease networks and pathways. Dr. Suk is the author of more than 200 papers published in peer-reviewed journals and holds patents on various therapeutic targets and lead compounds that could be used for the diagnosis or therapy of neuroinflammatory and neurodegenerative diseases.

)

Kyungpook National University
Daegu
Republic of Korea

N. Akaike
Kumamoto Health Science University
Kumamoto
Japan

K. A. Alkadhi
University of Houston
Houston, TX
USA

W. Araki (Biography
W. Araki

Dr. Araki received his medical doctor’s degree and Ph.D. degree at Kyoto University in 1985 and 1992, respectively. He had postdoctoral training at the National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), Tokyo, Japan and Massachusetts Institute of Technology, U.S.A. He has been working as a section chief at the National Institute of Neuroscience, NCNP since 1998. He is an author of more than 60 peer-reviewed publications.

)

National Institute of Neuroscience
Tokyo
Japan

P.J. Atkinson (Biography
P.J. Atkinson

Dr. Atkinson obtained a doctorate (Ph.D) in Cell Physiology and Pharmacology from the University of Leicester (UK). In his role as Associate Director, Open Innovation, Peter contributes to the strategic direction and management of external scientific collaborations to enable target validation and lead generation within Eisai’s Neurology Business Group. This builds upon over 15 years working as a pharmacologist in neuroscience drug discovery for Wyeth (USA) and GlaxoSmithKline (UK). During this time Peter led preclinical neuroscience programs working extensively with global, multidisciplinary project teams. Peter has published a number of peer-reviewed scientific manuscripts within neuropharmacology and drug discovery research field.

)

Neuroscience and General Medicine PCU, Mosquito Way Hatfield Hertfordshire Eisai Ltd.
UK

B. A. Bahr (Biography
B. A. Bahr

Professor Bahr is trained in the fields of chemistry, molecular biology, and neuroscience and is the lead investigator for several grants studying Alzheimer’s disease and other brain disorders. Upon receiving his Ph.D. from University of California–Santa Barbara, Dr. Bahr joined the Center for the Neurobiology of Learning and Memory at University of California–Irvine as a researcher and lecturer. Currently, Dr. Bahr is the William C. Friday Chair and Distinguished Professor at the Pembroke campus of University of North Carolina. He has over 140 publications and several patents and pending patents on first-in-class neuroprotective compounds and their uses.

)

University of North Carolina - Pembroke Pembroke
North Carolina, NC
USA

K. Ballanyi
University of Alberta
Edmonton
Canada

M. L. Barbaccia
University of Rome Tor Vergata- Medical School
Rome
Italy

M. Basselin
National Institutes of Health
Bethesda, MD
USA

Al J Beitz
University of Minnesota
St. Paul, MN
USA

F. M. Benes
Harvard Medical School
Boston, MA
USA

B. Bettler
Physiologisches Institut
Basel
Switzerland

P. Blandina
Universit agli Studi di Firenze
Firenze
Italy

D. Boison ()
Dow Neurobiology Laboratories
Portland

A. Bordey
University School of Medicine
New Haven, CT
USA

R. Brandt (Biography
R. Brandt

Roland Brandt studied biochemistry and philosophy at the Universities of Tübingen and Berlin. After obtaining his doctoral degree at the Free University of Berlin, he continued as postdoctoral researcher at the Center for Neurologic Diseases (CND) at Harvard Medical School, Boston (USA). After returning to Germany, he became an independent research group leader at the Interdisciplinary Center for Neuroscience (IZN) of the University of Heidelberg. Since 2002 he is Full Professor and Head of the Department of Neurobiology at the University of Osnabrück. He has published more than 80 scientific publications, co-edited two books and is currently editorial board member of “Current Neuropharmacology”, review editor of “Frontiers in Neurodegeneration”, associate editor of “Biological Chemistry”, and honorary editorial board member of “Brain Research Bulletin”.

)

Universitaet Osnabrck
Osnabrück
Germany

A. W. Bruijnzeel
University of Florida
Gainesville, FL
USA

I. Bókkon
Semmelweis University.
Budapest
Hungary

G. A. Caldwell (Biography
G. A. Caldwell

Guy A. Caldwell, Ph.D., is a University Distinguished Research Professor at The University of Alabama. He also holds an appointments at the University of Alabama School of Medicine in Birmingham as an Adjunct Research Professor in the Departments of Neurology and Neurobiology, where he is also a scientist in the Center for Neurodegeneration and Experimental Therapeutics. Dr. Caldwell received his undergraduate degree in Biology from Washington & Lee University and his Ph.D. in Cell, Molecular & Developmental Biology from The University of Tennessee. As a postdoc at Columbia University in the lab of 2008 Nobel Laureate, Dr. Martin Chalfie, he was twice named the recipient of fellowships from the National Institutes of Health. Dr. Caldwell serves on the editorial boards of Human Molecular Genetics, Disease Models and Mechanisms, ACS Chemical Neuroscience, and Current Neuropharmacology. Dr. Caldwell was honored in U.S. Congress with the 2005 Carnegie Foundation and Council for the Advancement and Support of Education (CASE) U.S. Professor of the Year award.

)

The University of Alabama
Tuscaloosa
USA

M. J. Christie
The University of Sydney
Sydney
Australia

C. C. Felder
Lilly Corporate Center
Indianapolis, IN
USA

M. Kalinichev
H. Lundbeck A/S
Copenhagen
Denmark

K. Liow
University of Kansas School of Medicine
Kansas, KS
USA

M. J. Millan
Inst. de Rech. Servier, Croissy
Paris
France

V. Mutel
Addex Pharmaceuticals SA
Geneva
Switzerland

M. Popoli (Biography
M. Popoli

MP is Professor of Pharmacology at University of Milano (Italy). He was trained in Biochemistry/Cell Biology at University of Naples and received postdoctoral training at Int. Inst. Genet. Biophysics (Naples), and Dept. of Psychiatry at Washington University, (St. Louis, MO).

His studies have contributed to characterization of cellular/molecular mechanisms involved in pathophysiology of neuropsychiatric disorders and psychotropic drug action. He received a NARSAD Independent Investigator Award, and funding from national and international agencies, including EU.

He is author of 120 publications, and currently field editor or editorial board member of neuropsychopharmacology/biological psychiatry journals.

)

University of Milano
Milano
Italy

T. Sharp
Oxford University
Oxford
UK

H. Takeda
Tokyo Medical University
Tokyo
Japan


Guest Editor(s):

Karim Alkadhi
Department of Pharmacological and Pharmaceutical Sciences 521E Science and Research 2 Bldg.
Houston, TX
USA


Advertisement

Related Journals




Related eBooks


Webmaster Contact: urooj@benthamscience.org Copyright © 2016 Bentham Science